Edaravone in acute ischemic stroke, an Indian experience

Neurology Asia

Volumn 14, Issue , 2009, Pages 7-10

  Sinha, M K ^a   Anuradha, H K ^a   Juyal, R ^a   Shukla, Rakesh ^a   Garg, R K ^a   Kar, A M ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NORPHENAZONE; ACETYLSALICYLIC ACID; MANNITOL; WARFARIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BARTHEL INDEX; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLASGOW COMA SCALE; HUMAN; INDIA; MALE; OUTCOME ASSESSMENT; RANKIN SCALE; SCORING SYSTEM;

EID: 70349644672     PISSN: 18236138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. H Yoshida, H Yanai, Y Namiki, K Fukatsu-Sasaki, N Furutani, N Tada. Neuroprotective effects of edaravone: a novel free radical scavenger. CNS Drug Rev 2006; 12(1):9-20.
2. Suda S, Igarashi H, Arai Y, Andou J, Chishiki T, Katayama Y. Effect of edaravone, a free radical scavenger on ischemic cerebral edema assessed by Magnetic Resonance Imaging. Neurol Med Chir (Tokyo) 2007; 47:197-201.
3. Edaravone Acute Brain Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Cerebrovasc Dis 2003; 15:222-9.
4. Mishina M, Komaba Y, Kobayashi S, et al. Efficacy of edaravone, a free radical scavenger for the treatment of acute lacunar infarction. Neurol Med Chir (Tokyo) 2005; 45:344-8.
5. Inatomi Y, Takita T, Yonehara T, et al. Efficacy of edaravone in cardioembolic stroke. Internal Medicine 2006; 45(5):253-7.
6. Toyoda K, Fujii K, Kamouchi M, et al. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J Neurol Sci 2004; 221(1-2):11-7.
7. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull WHO 1976; 54:541-53.
8. Goldstein LB, Jones MR, Matchar DB, et al. Improving the reliability of stroke subgroup classification using the Trial of ORG10172 in Acute Stroke Treatment (TOAST) criteria. Stroke 2001; 32(5):1091-8.
9. Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999; 30(8):1538-41.
10. Otomo E, Tohgi H, Kogure K, et al. Clinical efficacy of a free radical scavenger, MCI-186, on acute cerebral infarction: Early phase II clinical trial. Ther Res 1998; 19: 531-52.
11. Abe M, Kaizu K, Matsumoto K. A case report of acute renal failure and fulminant hepatitis associated with edaravone administration in a cerebral infarction patient. Ther Apher Dial 2007; 11(3):235-40.
12. Hishida A. Clinical analysis of 207 patients who developed renal disorders during or after treatment with edaravone reported during post-marketing surveillance. Clin Exp Nephrol 2007; 11(4):292-6.